eMedicine Specialties > Infectious Diseases > Sexually Transmitted Diseases

Chancroid

Author: Alexandre F Migala, DO, Staff Physician, Department of Emergency Medicine, Denton Regional Medical Center
Coauthor(s): Gregory Shipkey, MD, Consulting Staff, Department of Emergency Medicine, MCH Medical Center, Odessa, Texas
Contributor Information and Disclosures

Updated: May 15, 2009

Introduction

Background

Chancroid is a sexually transmitted disease (STD) characterized by one or more painful genital ulcers usually accompanied by painful inguinal lymphadenopathy. The infection, while worldwide in distribution, generally is uncommon in industrialized countries; however, difficulty in definitively diagnosing the infection may somewhat cloud the true incidence of this infection.1,2

This photograph shows an early chancroid on the p...

This photograph shows an early chancroid on the penis, along with accompanying regional lymphadenopathy. Courtesy of the CDC/Dr. Pirozzi.

This photograph shows an early chancroid on the p...

This photograph shows an early chancroid on the penis, along with accompanying regional lymphadenopathy. Courtesy of the CDC/Dr. Pirozzi.

Pathophysiology

Chancroid is caused by the small, gram-negative, facultative anaerobic bacillus Haemophilus ducreyi, which produces a cytocidal distending toxin that appears to be responsible for its toxic effects. Transmitted by direct contact, the organism has an incubation period from 1 day to 2 weeks, with a median time of 5-7 days. The disease typically begins as a small inflammatory papule at the site of inoculation; within days, the papule erodes to form an extremely painful deep ulceration.3,4,5

Frequency

United States

The incidence of chancroid has declined steadily from 1987 (when >5000 cases were reported to the Centers for Disease Control and Prevention [CDC]) to 1997 (when only 243 cases were reported involving a total of 19 different states). The disease is considered endemic in several large US cities, and 85% of the 243 cases reported in 1997 were confined to California, New York, Texas, and South Carolina. Epidemics of disease are associated with low socioeconomic status, poor hygiene, prostitution, and drug abuse. In 2003, only 54 cases were reported to the CDC, with 24 of these cases from South Carolina. The true incidence is difficult to determine and is likely largely underestimated because of the difficulties in culturing H ducreyi.

International

Worldwide, the true incidence of chancroid may surpass that of syphilis. Extremely common in Africa, the Caribbean basin, and Southwest Asia, the disease is thought to be the most common cause of genital ulceration in Kenya, Gambia, and Zimbabwe.

Mortality/Morbidity

  • Chancroid is characterized by painful genital ulcers, which are associated with a unilateral painful inguinal lymphadenopathy in 50% of the population. Left untreated, suppurative bubo formation occurs in approximately 25% of cases, which can progress to spontaneous rupture with formation of a deep nonhealing inguinal ulcer. Chancroid is easily curable with appropriate antibiotic therapy, although patients with HIV require longer courses of therapy. The true impact of the disease lies in the well-known association of genital ulcer disease with increased transmission rates of HIV and other STDs.
  • Superinfection of lesions, known as phagedenic chancroid, may lead to widespread disfiguring necrosis and may require surgical excision.

Race

Although no proven racial predilection exists, chancroid is most commonly observed in nonwhite people.

Sex

Chancroid is most commonly observed in nonwhite men who are uncircumcised. Women represent only 10% of known cases because they are more likely to be asymptomatic carriers.

Chancroid is more commonly identified in individuals of lower socioeconomic status, prostitutes and travellers from endemic areas. According to Benson and Hergenroeder,6 there have been no reported cases of chancroid among homosexual males, bisexuals or lesbian females.

Age

Although it can affect people of any age, chancroid predominantly affects younger sexually active people. Females aged 15-19 years have the highest prevalence among women in the United States, followed by those aged 20-24 years. In males, the highest prevalence is in those aged 20-24 years.

Clinical

History

  • Patients usually present with single or multiple painful genital ulcers.
  • In women with lesions of the vulva, vagina, or cervix, the chief symptom may be dysuria or dyspareunia.
  • Painful inguinal lymphadenopathy, usually unilateral, develops in approximately 30-60% of patients within 1-2 weeks.

Physical

  • Lesions
    • The lesion of chancroid begins as a small tender papule with surrounding erythema that rapidly becomes pustular and then erodes to form an extremely painful and deep ulcer with soft (compared to the chancre of syphilis) ragged margins.
    • The ulcer base is composed of easily friable granulation tissue that is usually covered with malodorous yellow-gray exudates.
    • Ulcers may be single or multiple, and as many as 10 ulcers have been reported on a single patient.
    • Men more commonly present with single ulcers, whereas women typically have multiple lesions.
    • Individual ulcers vary in size from 1-20 mm, with 1-2 cm being the most common size.
    • In circumcised men, lesions are most commonly found on the coronal sulcus; in uncircumcised men, the lesions are commonly found on the prepuce. Lesions may be obscured by a painful phimosis in uncircumcised men.
    • In women, lesions most commonly are found on the fourchette, labia, vestibule, clitoris, cervix, and anus.
    • In both men and women, adjacent lesions may merge and form confluent lesions.
    • Superinfection of ulcers, especially fusospirochetal, may occur and lead to rapid destruction of the external genitalia, known as phagedenic chancroid.
  • Lymphadenopathy: Painful, usually unilateral, regional lymphadenopathy occurs in 30-60% of patients and is more common in men. Of the patients with lymphadenitis, 25% may have progression to a suppurative bubo, which may rupture spontaneously and ulcerate. If untreated, chronic draining sinuses may follow.
  • Other types of chancroid: Although relatively rare, chancroid sometimes may be associated with a variety of presentations different from the classic form described above.
    • Transient chancroid produces an ulcer that rapidly resolves in 4-6 days, followed 10-20 days later by a suppurative lymphadenitis.
    • Dwarf chancroid manifests as one or several herpeslike ulcerations, with or without inguinal lymphadenopathy.
    • Follicular chancroid produces ulcerations of the pilar apparatus in hair-bearing areas.
    • Giant chancroid consists of multiple small ulcerations, which coalesce to form a single large lesion.
  • Pseudogranuloma inguinale is another chancroid variety that closely resembles granuloma inguinale.

Causes

Chancroid is an STD resulting from direct contact with H ducreyi. Risk factors include residing in an endemic area, lower socioeconomic status, prostitution, and drug abuse.

More on Chancroid

Overview: Chancroid
Differential Diagnoses & Workup: Chancroid
Treatment & Medication: Chancroid
Follow-up: Chancroid
Multimedia: Chancroid
References
Further Reading

References

  1. Janowicz DM, Ofner S, Katz BP, Spinola SM. Experimental Infection of Human Volunteers with Haemophilus ducreyi: Fifteen Years of Clinical Data and Experience. J Infect Dis. Jun 1 2009;199(11):1671-9. [Medline].

  2. Mohammed TT, Olumide YM. Chancroid and human immunodeficiency virus infection--a review. Int J Dermatol. Jan 2008;47(1):1-8. [Medline].

  3. Bauer ME, Townsend CA, Doster RS, Fortney KR, Zwickl BW, Katz BP, et al. A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans. J Infect Dis. Mar 1 2009;199(5):684-92. [Medline].

  4. Leduc I, Banks KE, Fortney KR, Patterson KB, Billings SD, Katz BP, et al. Evaluation of the repertoire of the TonB-dependent receptors of Haemophilus ducreyi for their role in virulence in humans. J Infect Dis. Apr 15 2008;197(8):1103-9. [Medline].

  5. Banks KE, Fortney KR, Baker B, Billings SD, Katz BP, Munson RS Jr, et al. The enterobacterial common antigen-like gene cluster of Haemophilus ducreyi contributes to virulence in humans. J Infect Dis. Jun 1 2008;197(11):1531-6. [Medline].

  6. Benson PA, Hergenroeder AC. Bacterial sexually transmitted infections in gay, lesbian, and bisexual adolescents: medical and public health perspectives. Semin Pediatr Infect Dis. Jul 2005;16(3):181-91. [Medline].

  7. Alfa M. The laboratory diagnosis of Haemophilus ducreyi. Can J Infect Dis Med Microbiol. Jan 2005;16(1):31-4. [Medline].

  8. Rosen T, Vandergriff T, Harting M. Antibiotic use in sexually transmissible diseases. Dermatol Clin. Jan 2009;27(1):49-61. [Medline].

  9. Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol. Oct 1999;41(4):511-32. [Medline].

  10. Czelusta A, Yen-Moore A, Van der Straten M. An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol. Sep 2000;43(3):409-32; quiz 433-6. [Medline].

  11. Hand WL. Haemophilus species including chancroid. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Pa:. Churchill Livingstone;2000:2380-2381.

  12. Lundqvist A, Kubler-Kielb J, Teneberg S, Ahlman K, Lagergård T. Immunogenic and adjuvant properties of Haemophilus ducreyi lipooligosaccharides. Microbes Infect. Mar 2009;11(3):352-60. [Medline].

  13. Rosen T, Brown TJ. Genital ulcers. Evaluation and treatment. Dermatol Clin. Oct 1998;16(4):673-85, x. [Medline].

  14. Schmid GP. Chancroid and granuloma inguinale. In: Kelley W, ed. Textbook of internal medicine. 3rd ed. Philadelphia, Pa:. Lippincott-Raven;1997:1670-1671.

  15. Tomecki. Chancroid and Haemophilus ducreyi: an update. J Am Acad Dermatol. 1997;36(5):776.

  16. Wang CC, Celum CL. Global risk of sexually transmitted diseases. Med Clin North Am. Jul 1999;83(4):975-95, vi. [Medline].

  17. Zuckerman JM. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am. 2004;18:621-649. [Medline].

Further Reading

Clinical guidelines

Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines 2006.
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. 1993 (revised 2006 Aug 4). 17 pages. NGC:005184

Chancroid. In: Sexually transmitted infections: UK national screening and testing guidelines.
British Association for Sexual Health and HIV - Medical Specialty Society. 2006 Aug. 5 pages. NGC:006398

Clinical prevention guidance. Sexually transmitted diseases treatment guidelines 2006.
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]. 1993 (revised 2006 Aug 4). 5 pages. NGC:005181

Clinical trials

Lay Health Advisors for Sexually Transmitted Disease Prevention

Related eMedicine topics

Chancroid (Dermatology)

Chancroid (Emergency Medicine)

Dermatologic Diseases of the Male Genitalia: Nonmalignant

Benign Cervical Lesions

Lymphogranuloma Venereum

Keywords

sexually transmitted diseases, STD, genital ulcers, inguinal lymphadenopathy, Haemophilus ducreyi, H ducreyi, phagedenic chancroid, suppurative bubo, transient chancroid, dwarf chancroid, follicular chancroid, giant chancroid, pseudogranuloma inguinale

Contributor Information and Disclosures

Author

Alexandre F Migala, DO, Staff Physician, Department of Emergency Medicine, Denton Regional Medical Center
Alexandre F Migala, DO is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Osteopathic Association, Association of Military Osteopathic Physicians and Surgeons, and Texas Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Gregory Shipkey, MD, Consulting Staff, Department of Emergency Medicine, MCH Medical Center, Odessa, Texas
Gregory Shipkey, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus
Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Charles V Sanders, MD, Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center
Charles V Sanders, MD is a member of the following medical societies: Alliance for the Prudent Use of Antibiotics, Alpha Omega Alpha, American Association for the Advancement of Science, American Association of University Professors, American Clinical and Climatological Association, American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Foundation for AIDS Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association for Professionals in Infection Control and Epidemiology, Association of American Medical Colleges, Association of American Physicians, Association of Professors of Medicine, Infectious Disease Society for Obstetrics and Gynecology, Infectious Diseases Society of America, Louisiana State Medical Society, Orleans Parish Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southeastern Clinical Club, Southern Medical Association, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.